1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Pathos | Scailyte |
|---|---|---|
| Founded | ||
| Founded | 2022 | 2017 older |
| Headquarters | ||
| Headquarters | Chicago, United States | Basel, Switzerland |
| Employees | ||
| Employees | 96 larger | 18 |
| Industry | ||
| Industry | Not tracked yet | AI, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series D | Series A |
| Total Funding | ||
| Total Funding | $365.00M | $21.12M |
| Funding Rounds | ||
| Funding Rounds | 3 | 9 |
| Services | ||
| Services | AI-driven Clinical Trials, Precision Therapy Discovery, Data Modeling for Oncology, Biopharmaceutical Collaboration | Autoimmune Foundation Model development, Advanced patient endotyping, Predictive disease modeling, Biomarker assays co-development, Pharma partnership facilitation |
| Target Customers | ||
| Target Customers | Biopharmaceutical Companies, Clinical Researchers, Healthcare Providers, Investors in Biotech | Pharmaceutical companies, Biotech firms, Clinical researchers, Healthcare providers, Decision-makers in precision medicine |
| Taxonomy | ||
| Taxonomy | AI-enabled Drug Development, Precision Oncology, Multimodal Patient Data, Oncology, Biomarker-driven Clinical Execution, Clinical Trials, Drug Discovery, Cancer Biology, Computational Biology, Biopharma, Model-driven Hypotheses, Precision Medicine | AI-driven Biomarker Discovery, Single-cell Omics, ScaiVision Platform, Oncology, Auto-immunity, Precision Medicine, Biomarker Signatures, Clinical Partnerships, Biotech Collaboration, Pharma Collaboration, Drug Development, Phenotypic Biomarker Discovery, Molecular Profiles, Disease Biology |
| Website | ||
| Website | pathos.com | scailyte.com |
About Pathos
Pathos, founded in 2022 and headquartered in the United States, is a clinical-stage, AI-enabled precision oncology biotech. Its slogan, "AI-enabled drug development built for patients", encapsulates its mission to revolutionize the biopharma sector. The company is pioneering the integration of AI w...
About Scailyte
Scailyte, founded in 2017 and headquartered in Basel, Switzerland, is a leader in AI-driven biomarker discovery from single-cell omics data. The company’s proprietary AI platform, ScaiVision, enables the analysis of over 60 million single-cell profiles. This capability positions Scailyte at the fore...
We will tell you when either one moves
BounceWatch watches Pathos and Scailyte for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Pathos and Scailyte — by email.
Frequently Asked Questions
Compare Pathos with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Pathos on 15 Jun 2026, and Scailyte on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.